Caligan Partners LP is an Activist Hedge Fund based in New York, NY led by Tiffany Crowley, managing $720.7M across 16 long positions as of Q3 2025 with 83% Healthcare concentration, 93% concentrated in top 10 holdings, and 26% allocation to LQDA.
Largest long holdings in Caligan Partners LP's portfolio (93.5% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $184.6M | 25.62% | — | 9.43% 8.1M shares | |
Unknown Unknown | $123.3M | 17.10% | -$18.9M Sold | — 1.5M shares | |
Biotechnology Healthcare | $105.1M | 14.59% | +$28.6M Bought | 3.57% 2.8M shares | |
Biotechnology Healthcare | $63.0M | 8.74% | — | 0.57% 1.5M shares | |
Biotechnology Healthcare | $49.7M | 6.90% | +$20.0M Bought | 0.57% 1.1M shares | |
Biotechnology Healthcare | $45.4M | 6.30% | +$2.4M Bought | 1.95% 1.1M shares | |
Biotechnology Healthcare | $38.7M | 5.36% | +$38.7M Bought | 1.10% 2.6M shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $25.4M | 3.53% | +$4.9M Bought | 6.40% 4.1M shares | |
Biotechnology Healthcare | $20.4M | 2.83% | -$41.4M Sold | 0.29% 217.0K shares | |
Biotechnology Healthcare | $17.8M | 2.48% | +$17.8M New | 0.58% 444.6K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Caligan Partners LP's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
+266.85% | |
+67.12% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
-66.98% |
Portfolio insights and performance metrics for Caligan Partners LP
We use cookies for analytics. See our Privacy and Cookie Policy.